Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer.

Laurent-Puig P, Grisoni ML, Heinemann V, Liebaert F, Neureiter D, Jung A, Montestruc F, Gaston-Mathe Y, Thiébaut R, Stintzing S.

Clin Cancer Res. 2019 Jan 1;25(1):134-141. doi: 10.1158/1078-0432.CCR-18-1324. Epub 2018 Aug 14.


Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.

Tarraf H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, Haouichat H, Khassawneh B, Mahboub B, Naghshin R, Montestruc F, Behbehani N.

Respir Med. 2018 May;138:64-73. doi: 10.1016/j.rmed.2018.03.024. Epub 2018 Mar 26.


Gait disorders in the elderly and dual task gait analysis: a new approach for identifying motor phenotypes.

Auvinet B, Touzard C, Montestruc F, Delafond A, Goeb V.

J Neuroeng Rehabil. 2017 Jan 31;14(1):7. doi: 10.1186/s12984-017-0218-1.


Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies.

Mekinian A, Bourrienne MC, Carbillon L, Benbara A, Noémie A, Chollet-Martin S, Tigaizin A, Montestruc F, Fain O, Nicaise-Roland P.

Semin Arthritis Rheum. 2016 Oct;46(2):232-7. doi: 10.1016/j.semarthrit.2016.05.006. Epub 2016 May 25.


Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review.

Grignano E, Mekinian A, Braun T, Liozon E, Hamidou M, Decaux O, Puéchal X, Kahn JE, Schoindre Y, Rossignol J, Lortholary O, Lioger B, Hermine O, Park S, Ades L, Montestruc F, Ricard L, Gardin C, Fenaux P, Fain O; GFM, SNFMI and CRI.

Leuk Res. 2016 Aug;47:136-41. doi: 10.1016/j.leukres.2016.05.013. Epub 2016 Jun 2.


Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study.

Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N, Kahn JE, Hamidou M, Park S, Puéchal X, Toussirot E, Falgarone G, Launay D, Morel N, Trouiller S, Mathian A, Gombert B, Schoindre Y, Lioger B, De Wazieres B, Amoura Z, Buchdaul AL, Georgin-Lavialle S, Dion J, Madaule S, Raffray L, Cathebras P, Piette JC, Rose C, Ziza JM, Lortholary O, Montestruc F, Omouri M, Denis G, Rossignol J, Nimubona S, Adès L, Gardin C, Fenaux P, Fain O.

Rheumatology (Oxford). 2016 Feb;55(2):291-300. doi: 10.1093/rheumatology/kev294. Epub 2015 Sep 8.


Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.

Mekinian A, Costedoat-Chalumeau N, Masseau A, Botta A, Chudzinski A, Theulin A, Emmanuelli V, Hachulla E, De Carolis S, Revaux A, Nicaise P, Cornelis F, Subtil D, Montestruc F, Bucourt M, Chollet-Martin S, Carbillon L, Fain O; SNFMI and the European Forum of APS.

Autoimmunity. 2015 Feb;48(1):40-5. doi: 10.3109/08916934.2014.939267. Epub 2014 Jul 16.


Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.

Moura DS, Sultan S, Georgin-Lavialle S, Pillet N, Montestruc F, Gineste P, Barete S, Damaj G, Moussy A, Lortholary O, Hermine O.

PLoS One. 2011;6(10):e26375. doi: 10.1371/journal.pone.0026375. Epub 2011 Oct 21.


A trial comparing local pain after subcutaneous injection of epoetin-beta versus darbepoetin-alpha in healthy volunteers.

Berthoux F, Ryckelynck JP, Rouanet S, Gelu-Mantoulet S, Montestruc F, Mouchel P, Choukroun G; Painless Investigators Coordinators.

Clin Nephrol. 2008 Jul;70(1):33-40.


Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.

Bronowicki JP, Ouzan D, Asselah T, Desmorat H, Zarski JP, Foucher J, Bourlière M, Renou C, Tran A, Melin P, Hézode C, Chevalier M, Bouvier-Alias M, Chevaliez S, Montestruc F, Lonjon-Domanec I, Pawlotsky JM.

Gastroenterology. 2006 Oct;131(4):1040-8. Epub 2006 Jul 24.


[Results from the observational study EPIGRAM: management of excess weight in general practice and follow-up of patients treated with orlistat].

Vray M, Joubert JM, Eschwège E, Liard F, Fagnani F, Montestruc F, Fages S, Bégaud B.

Therapie. 2005 Jan-Feb;60(1):17-24. French.


Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

Fumoleau P, Largillier R, Clippe C, Dièras V, Orfeuvre H, Lesimple T, Culine S, Audhuy B, Serin D, Curé H, Vuillemin E, Morère JF, Montestruc F, Mouri Z, Namer M.

Eur J Cancer. 2004 Mar;40(4):536-42.


Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers.

Pecking M, Montestruc F, Marquet P, Wodey E, Homery MC, Dostert P.

Br J Clin Pharmacol. 2002 Oct;54(4):357-62.


Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study).

Pellegrin I, Breilh D, Montestruc F, Caumont A, Garrigue I, Morlat P, Le Camus C, Saux MC, Fleury HJ, Pellegrin JL.

AIDS. 2002 Jul 5;16(10):1331-40.


MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine.

Katlama C, Pellegrin JL, Lacoste D, Aquilina C, Raffi F, Pialoux G, Vittecoq D, Raguin G, Lantz O, Mouroux M, Calvez V, Trylesinski A, Montestruc F, Dohin E, Goehrs JM, Delfraissy JF.

HIV Med. 2001 Jan;2(1):20-6.


Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation.

Colombat P, Salles G, Brousse N, Eftekhari P, Soubeyran P, Delwail V, Deconinck E, Haïoun C, Foussard C, Sebban C, Stamatoullas A, Milpied N, Boué F, Taillan B, Lederlin P, Najman A, Thièblemont C, Montestruc F, Mathieu-Boué A, Benzohra A, Solal-Céligny P.

Blood. 2001 Jan 1;97(1):101-6.


Calcium antagonists and thiazide diuretics have opposite effects on blood rheology and radial artery compliance in arterial hypertension: a randomized double-blind study.

Khder Y, Bray des Boscs L, el Ghawi R, Meilhac B, Montestruc F, Stoltz JF, Zannad F.

Fundam Clin Pharmacol. 1998;12(4):457-62.


[Efficacy and tolerability of pristinamycin vs amoxicillin-clavulanic acid combination in the treatment of acute community-acquired pneumonia in hospitalized adults].

Poirier R, Chardon H, Beraud A, Debieuvre D, Petitprez P, Montestruc F, Lilienthal F, Janus C.

Rev Pneumol Clin. 1997;53(6):325-31. French.


Supplemental Content

Loading ...
Support Center